AXGN

#2056
Axogen, Inc. Common Stock
34.4600 USD
+2.96%
Settore: Salute
Base: USD
Valuta di Profitto: USD
Intervallo Giornaliero
34.4600
34.4600
Intervallo Annuale
17.1400
35.9999
Variazione giornaliera
+2.96%
Variazione Mensile
+5.03%
Variazione di 6 mesi
+88.93%
Variazione Annuale
+88.93%
Chiusura Precedente
33.4700
Apertura
34.4600
Bid
Ask
Minimo
34.4600
High
34.4600
Volume
111
Apri il grafico completo

Financials

Panoramica Estratto Conto Statistiche Dividendi
Trimestrale Annuale
Conto economico Bilancio Liquidità
Valore 202020212022202320242025 TTM

Axogen Inc

Axogen is a developer of surgical solutions, including human tissue grafts, based in Alachua, Florida. Axogen products are designed to remedy peripheral nerve damage. In 2013 the company raised $18 million in its initial public offering. Axogen uses a cell graft technology AVANCE to mimic a human nerve. The company also creates nerve connectors and soft tissue membranes. The company reports sensory and movement recovery in 87 percent of patients with peripheral nerve injuries. Axogen is part of the Sid Martin Biotechnology Incubator. As of 2019, Axogen was the only commercially available allograft approved by the Food and Drug Administration for clinical use.

Notizie